Compare XRAY & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRAY | BLFS |
|---|---|---|
| Founded | 1899 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2009 | 2013 |
| Metric | XRAY | BLFS |
|---|---|---|
| Price | $8.74 | $36.78 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 9 |
| Target Price | $13.73 | ★ $31.29 |
| AVG Volume (30 Days) | ★ 4.1M | 760.0K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | 33.04 | ★ 77.27 |
| EPS | 0.14 | ★ 0.94 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.76 |
| Revenue Next Year | $1.47 | $17.03 |
| P/E Ratio | $64.57 | ★ $41.62 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $8.90 | $17.86 |
| 52 Week High | $14.73 | $39.76 |
| Indicator | XRAY | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 28.67 | 64.77 |
| Support Level | N/A | $34.38 |
| Resistance Level | $10.66 | N/A |
| Average True Range (ATR) | 0.36 | 0.91 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 5.69 | 78.83 |
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.